Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main Bluebird Bio, Inc. Transaction History

Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main

$92.1 Billion
Q2 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 15, 2022	SELL	$2.94 - $5.23 $2,058 - $3,661	-700 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$34.44 - $43.75 $24,108 - $30,625	700 New	700 $38,000

Others Institutions Holding BLUE

# of Institutions

162

Shares Held

79.9M

Call Options Held

525K

Put Options Held

634K

Black Rock Inc. New York, NY

15.4M
Shares

$7.72 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

10.3M
Shares

$5.15 Million
0.0% of portfolio
Ameriprise Financial Inc Minneapolis, MN

6.39M
Shares

$3.2 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

5.15M
Shares

$2.57 Million
0.0% of portfolio
Pictet Asset Management Sa Geneva 73, V8

4.67M
Shares

$2.33 Million
0.02% of portfolio

View Full List

About bluebird bio, Inc.

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $38.6M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

More about BLUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main, based on Form 13F filings with the SEC.

News

Stay updated on Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main with notifications on news.

Account